|
Volumn 37, Issue 1, 2005, Pages 57-63
|
A stability indicating LC method for Rivastigmine hydrogen tartrate
|
Author keywords
Alzheimer's disease; Forced degradation; Pharmaceutical dosage form; Rivastigmine hydrogen tartrate; RPLC; Solution and mobile phase stability; Validation
|
Indexed keywords
3 (1 DIMETHYLAMINOETHYL)PHENOL;
ACETONITRILE;
HYDROCHLORIC ACID;
HYDROGEN PEROXIDE;
PHENOL DERIVATIVE;
RIVASTIGMINE;
SODIUM HYDROXIDE;
UNCLASSIFIED DRUG;
ACCURACY;
AQUEOUS SOLUTION;
ARTICLE;
DRUG IMPURITY;
EXTRACTION;
HEATING;
INSTRUMENT;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVERSED PHASE LIQUID CHROMATOGRAPHY;
ULTRAVIOLET RADIATION;
VALIDATION PROCESS;
CHROMATOGRAPHY, LIQUID;
DRUG STABILITY;
PHENYLCARBAMATES;
|
EID: 12344324779
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2004.09.041 Document Type: Article |
Times cited : (41)
|
References (8)
|